GlassScriptPhysician profile
Joseph Bennett Mcgehee
NPI 1528221207
$34,736.71
in general payments reported to CMS, 2019-2025
18 companies · $8,680 in 2025
The $8,680 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $8,376 · 2021: $8,617 · 2022: $8,525 · 2023: $264 · 2024: $170 · 2025: $8,680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,000 · Food and Beverage: $1,113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,000.00 |
| Food and Beverage | $1,113.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $33,404.22 | 2020-2025 | |
| Abbvie INC. | $467.69 | 2019-2025 | |
| Astellas Pharma US INC | $199.54 | 2023-2025 | Veozah |
| Daiichi Sankyo INC. | $164.83 | 2019-2024 | Injectafer |
| Mayne Pharma Commercial LLC | $77.97 | 2023-2024 | |
| Aspira Women'S Health INC | $76.80 | 2021 | |
| Boston Scientific Corporation | $68.49 | 2019-2024 | Solyx Sis System |
| Exeltis, USA INC. | $63.62 | 2023-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $32.41 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.52 | 2021-2022 | |
| Avion Pharmaceuticals | $26.58 | 2019-2021 | |
| Lupin INC. | $23.79 | 2019-2020 | |
| Hologic Sales and Service, LLC | $21.50 | 2023 | Myosure Tissue Removal Device |
| Smith+Nephew, INC. | $21.17 | 2025 | Pico 7 |
| Shield Therapeutics INC | $18.61 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $14.93 | 2022 | |
| Coopersurgical, INC. | $13.72 | 2019 | |
| Pfizer INC. | $12.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Mcgehee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.